Request Demo
Last update 07 Nov 2026
Cetuximab biosimilar (EnZene Biosciences)
Last update 07 Nov 2026
Overview
Basic Info
Drug Type Biosimilar, Monoclonal antibody |
Synonyms- |
Target |
Action antagonists |
Mechanism EGFR antagonists(Epidermal growth factor receptor erbB1 antagonists) |
Therapeutic Areas |
Active Indication |
Inactive Indication- |
Originator Organization |
Active Organization |
Inactive Organization- |
License Organization |
Drug Highest PhaseClinical |
First Approval Date- |
Regulation- |
Structure/Sequence
Sequence Code 43254L
The sequence is quoted from: *****
Sequence Code 9505399H
The sequence is quoted from: *****
Related
2
Clinical Trials associated with Cetuximab biosimilar (EnZene Biosciences)CTRI/2024/08/072751
A prospective, multicenter, Phase IV study to evaluate the safety and efficacy of biosimilar cetuximab either alone or in combination with investigator choice chemotherapy/ radiotherapy in patients with locoregionally advanced or recurrent locoregional or metastatic squamous cell carcinoma of the head and neck (SCCHN). - NIL
CTRI/2019/09/021256
A prospective, multicenter, randomized, double blind, parallel group study to compare the efficacy and safety of biosimilar cetuximab versus innovator cetuximab in combination withplatinum-based chemotherapy in patients with recurrent locoregional or metastatic squamous cell carcinoma of the head and neck (SCCHN).
100 Clinical Results associated with Cetuximab biosimilar (EnZene Biosciences)
Login to view more data
100 Translational Medicine associated with Cetuximab biosimilar (EnZene Biosciences)
Login to view more data
100 Patents (Medical) associated with Cetuximab biosimilar (EnZene Biosciences)
Login to view more data
100 Deals associated with Cetuximab biosimilar (EnZene Biosciences)
Login to view more data
External Link
| KEGG | Wiki | ATC | Drug Bank |
|---|---|---|---|
| D03455 | Cetuximab biosimilar (EnZene Biosciences) |
R&D Status
10 top R&D records. to view more data
Login
| Indication | Highest Phase | Country/Location | Organization | Date |
|---|---|---|---|---|
| Squamous Cell Carcinoma | Clinical | - | - |
Login to view more data
Clinical Result
Clinical Result
Indication
Phase
Evaluation
View All Results
Login to view more data
Translational Medicine
Boost your research with our translational medicine data.
login
or
Deal
Boost your decision using our deal data.
login
or
Core Patent
Boost your research with our Core Patent data.
login
or
Clinical Trial
Identify the latest clinical trials across global registries.
login
or
Approval
Accelerate your research with the latest regulatory approval information.
login
or
Biosimilar
Competitive landscape of biosimilars in different countries/locations. Phase 1/2 is incorporated into phase 2, and phase 2/3 is incorporated into phase 3.
login
or
Regulation
Understand key drug designations in just a few clicks with Synapse.
login
or
Hiro LS Researcher
The AI Search Engine Built to Accelerate Biopharma Decisions
Search across billion-scale life sciences data to uncover signals, validate evidence, and act with confidence.
Ask any biopharma research question→
Get started for free today!
Accelerate Strategic R&D decision making with Synapse, Patsnap’s AI-powered Connected Innovation Intelligence Platform Built for Life Sciences Professionals.
Discover Synapse Data Servers
Synapse data is now integrated into the PatSnap LS Model Context Protocol (MCP) service. Customize your LLM agent now using our MCP server!
Bio
Bio Sequences Search & Analysis
Sign up for free
Chemical
Chemical Structures Search & Analysis
Sign up for free